Cargando…

In vitro activity of celastrol in combination with thymol against carbapenem-resistant Klebsiella pneumoniae isolates

Klebsiella pneumoniae is an opportunistic pathogen causing nosocomial and community-acquired infections. Klebsiella has developed resistance against antimicrobials including the last resort class; carbapenem. Currently, treatment options for carbapenem-resistant-Klebsiella (CRK) are very limited. Th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abdel-Halim, Mahmoud Saad, Askoura, Momen, Mansour, Basem, Yahya, Galal, El-Ganiny, Amira M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9640353/ https://www.ncbi.nlm.nih.gov/pubmed/36167781 http://dx.doi.org/10.1038/s41429-022-00566-y

Ejemplares similares

Isolation of a bacteriophage targeting Pseudomonas aeruginosa and exhibits a promising in vivo efficacy
por: Abdelghafar, Aliaa, et al.
Publicado: (2023)

A novel lytic phage exhibiting a remarkable in vivo therapeutic potential and higher antibiofilm activity against Pseudomonas aeruginosa
por: Abdelghafar, Aliaa, et al.
Publicado: (2023)

Celastrol mitigates staphyloxanthin biosynthesis and biofilm formation in Staphylococcus aureus via targeting key regulators of virulence; in vitro and in vivo approach
por: Yehia, Fatma Al-zahraa A., et al.
Publicado: (2022)

Correction: Celastrol mitigates staphyloxanthin biosynthesis and biofilm formation in Staphylococcus aureus via targeting key regulators of virulence; in vitro and in vivo approach
por: Yehia, Fatma Al-zahraa A., et al.
Publicado: (2022)

Antibiofilm and staphyloxanthin inhibitory potential of terbinafine against Staphylococcus aureus: in vitro and in vivo studies
por: Askoura, Momen, et al.
Publicado: (2022)

The Link between Occurrence of Class I Integron and Acquired Aminoglycoside Resistance in Clinical MRSA Isolates
por: El-Baz, Ahmed M., et al.
Publicado: (2021)

In vitro Activity of Apramycin Against Carbapenem-Resistant and Hypervirulent Klebsiella pneumoniae Isolates
por: Hao, Mingju, et al.
Publicado: (2020)

In vitro evaluation of antibiotic synergy for carbapenem-resistant Klebsiella pneumoniae clinical isolates
por: Goel, Anku, et al.
Publicado: (2021)

Molecular Characterization of Carbapenem Resistant Klebsiella pneumoniae and Klebsiella quasipneumoniae Isolated from Lebanon
por: Arabaghian, Harout, et al.
Publicado: (2019)

Resistome of carbapenem- and colistin-resistant Klebsiella pneumoniae clinical isolates
por: Lomonaco, Sara, et al.
Publicado: (2018)

Limiting and controlling carbapenem-resistant Klebsiella pneumoniae
por: Saidel-Odes, Lisa, et al.
Publicado: (2013)

No Carbapenem Resistance in Pneumonia Caused by Klebsiella Species
por: Yayan, Josef, et al.
Publicado: (2015)

Epidemiological Study of Carbapenem-resistant Klebsiella Pneumoniae
por: Lin, Di, et al.
Publicado: (2018)

Risk Factors for Carbapenem-resistant Klebsiella pneumoniae Infection and Mortality of Klebsiella pneumoniae Infection
por: Wang, Zhe, et al.
Publicado: (2018)

Risk Factors for Subsequential Carbapenem-Resistant Klebsiella pneumoniae Clinical Infection Among Rectal Carriers with Carbapenem-Resistant Klebsiella pneumoniae
por: Chen, Xia, et al.
Publicado: (2020)

In Vitro Investigation of the Impact of Bacterial–Fungal Interaction on Carbapenem-Resistant Klebsiella pneumoniae
por: Moubasher, Hani, et al.
Publicado: (2022)

Carbapenem-Resistant Klebsiella pneumoniae: Diversity, Virulence, and Antimicrobial Resistance
por: Elmanakhly, Arwa R, et al.
Publicado: (2022)

Prevalence of Carbapenem-Resistant Hypervirulent Klebsiella pneumoniae and Hypervirulent Carbapenem-Resistant Klebsiella pneumoniae in China Determined via Mouse Lethality Tests
por: Hu, Dakang, et al.
Publicado: (2022)

Molecular Characterization of Klebsiella pneumoniae Clinical Isolates with Elevated Resistance to Carbapenems
por: Barwa, Rasha, et al.
Publicado: (2017)

Rapid Nanopore Assay for Carbapenem-Resistant Klebsiella pneumoniae
por: Niu, Haofu, et al.
Publicado: (2019)

Rapid susceptibility profiling of carbapenem-resistant Klebsiella pneumoniae
por: Mulroney, K. T., et al.
Publicado: (2017)

The Metabolome of Carbapenem-Resistant Klebsiella pneumoniae Infection in Plasma
por: Wen, Zhongwei, et al.
Publicado: (2021)

Carbapenem-Resistant Klebsiella pneumoniae Associated with COVID-19
por: Dumitru, Irina Magdalena, et al.
Publicado: (2021)

Heteroresistance to Amikacin in Carbapenem-Resistant Klebsiella pneumoniae Strains
por: Zhang, Feiyang, et al.
Publicado: (2021)

In Vitro Activity of Carbapenems Alone and in Combination With Amikacin Against KPC-Producing Klebsiella Pneumoniae
por: Le, Jennifer, et al.
Publicado: (2011)

Heteroresistance Is Associated With in vitro Regrowth During Colistin Treatment in Carbapenem-Resistant Klebsiella pneumoniae
por: Wang, Yifan, et al.
Publicado: (2022)

Synergistic Antibiofilm Efficacy of Thymol and Piperine in Combination with Three Aminoglycoside Antibiotics against Klebsiella pneumoniae Biofilms
por: Bisso Ndezo, Borel, et al.
Publicado: (2021)

Genomic Features Associated with the Degree of Phenotypic Resistance to Carbapenems in Carbapenem-Resistant Klebsiella pneumoniae
por: Bulman, Zackery P., et al.
Publicado: (2021)

Carbapenem-resistant Klebsiella pneumoniae in high-risk haematological patients: factors favouring spread, risk factors and outcome of carbapenem-resistant Klebsiella pneumoniae bacteremias
por: Micozzi, Alessandra, et al.
Publicado: (2017)

Satisfactory In Vitro Activity of Ceftolozane–Tazobactam against Carbapenem-Resistant Pseudomonas aeruginosa But Not against Klebsiella pneumoniae Isolates
por: Sękowska, Alicja, et al.
Publicado: (2023)

The threat of colistin resistance among carbapenem-resistant Klebsiella pneumoniae isolates in Iran
por: Haeili, Mehri, et al.
Publicado: (2018)

Molecular characterization of carbapenem-resistant Klebsiella pneumoniae isolates with focus on antimicrobial resistance
por: Yu, Xiaoling, et al.
Publicado: (2019)

Molecular epidemiology and mechanisms of tigecycline resistance in carbapenem‐resistant Klebsiella pneumoniae isolates
por: Park, Yumi, et al.
Publicado: (2020)

Celastrol Modulates Multiple Signaling Pathways to Inhibit Proliferation of Pancreatic Cancer via DDIT3 and ATF3 Up-Regulation and RRM2 and MCM4 Down-Regulation
por: Youns, Mahmoud, et al.
Publicado: (2021)

Emergence of Colistin and Carbapenem Resistance in Extended-Spectrum β-Lactamase Producing Klebsiella pneumoniae Isolated from Chickens and Humans in Egypt
por: Elmonir, Walid, et al.
Publicado: (2021)

Synergetic Effects of Combined Treatment of Colistin With Meropenem or Amikacin on Carbapenem-Resistant Klebsiella pneumoniae in vitro
por: Yu, Lan, et al.
Publicado: (2019)

Carbapenem Resistance in Klebsiella pneumoniae Not Detected by Automated Susceptibility Testing
por: Tenover, Fred C., et al.
Publicado: (2006)

Epidemiology of Carbapenem Resistant Klebsiella pneumoniae Infections in Mediterranean Countries
por: Girmenia, Corrado, et al.
Publicado: (2016)

Review of therapeutic options for infections with carbapenem-resistant Klebsiella pneumoniae
por: BANDICK, RASMUS G., et al.
Publicado: (2020)

Molecular Characterization of Carbapenem Resistant Klebsiella pneumoniae in Malaysia Hospital
por: Lau, Min Yi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_au938h3e8feuv9up9kblg02tvn